D-lysergic acid diethylamide (LSD 25), first synthesized in 1938, is a synthetic amide that induces psychic states where subjects become aware of repressed memories and unconscious material while remaining conscious. In a one-year preliminary study of 36 psychoneurotic patients, the drug shows promise for treating psychoneuroses and related mental illnesses.
Lysergic acid diethylamide (LSD) shows promise in treating mental illness, based on clinical experience gained since an earlier report. The paper describes outcomes from continued use of the drug in therapeutic settings, detailing its effects on patients with various mental disorders. The authors suggest that LSD can facilitate psychological insight and improve symptoms in some cases, though they note limitations and the need for careful administration. The account provides a qualitative assessment of the drug's potential as a treatment tool, grounded in observed patient responses over an extended period.